Clinical Trial

Protein A Immunoadsorption in Dilated Cardiomyopathy (RPIA-DCM)

Recruiting
View on ClinicalTrials.gov →
Summary
This study is a multicenter, dual-arm and randomized controlled clinical trial. Sixty patients with dilated cardiomyopathy and positive β1-adrenergic receptor autoantibodies were selected and randomly divided into an immunoadsorption group (receiving immunoadsorption therapy) and a control group in a 1:1 ratio. Changes in cardiac function, morphology and clinical outcomes were followed up and compared.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-04-03; most recent amendment 2025-05-30.
Status change: Not Yet Recruiting → Recruiting 2025-05-30
Trial Details
NCT Number NCT06922851
Lead Sponsor Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions Dilated Cardiomyopathy (DCM)
Enrollment 60 participants
Start Date 2025-06-04
Primary Completion 2026-12-31 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-06-04